• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管磁共振成像在运动心脏病学中的作用:当前应用与未来展望

The Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future Perspectives.

作者信息

Androulakis Emmanuel, Swoboda Peter P

机构信息

St George's University Hospitals NHS Foundation Trust, London, UK.

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds, LS2 9JT, UK.

出版信息

Curr Treat Options Cardiovasc Med. 2018 Aug 31;20(10):86. doi: 10.1007/s11936-018-0679-y.

DOI:10.1007/s11936-018-0679-y
PMID:30167977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6132733/
Abstract

PURPOSE OF REVIEW

Cardiovascular magnetic resonance (CMR) is frequently used in the investigation of suspected cardiac disease in athletes. In this review, we discuss how CMR can be used in athletes with suspected cardiomyopathy with particular reference to volumetric analysis and tissue characterization. We also discuss the finding of non-ischaemic fibrosis in athletes describing its prevalence, distribution and clinical importance.

RECENT FINDINGS

The strengths of CMR include high spatial resolution, unrestricted imaging planes and lack of ionizing radiation. Regular physical exercise leads to cardiac remodeling that in certain situations can be clinically challenging to differentiate from various cardiomyopathies. Thorough morphological assessment by CMR is fundamental to ensuring accurate diagnosis. Developments in tissue characterization by late gadolinium enhancement and T1 mapping have the potential to be powerful additional tools in this challenging clinical situation. Using late gadolinium enhancement, it is also possible to detect non-ischaemic fibrosis in athletes who do not have overt cardiomyopathy. The mechanisms of this fibrosis are unclear; however, it does appear to be clinically important. We also review data on the prevalence of non-ischaemic fibrosis in athletes. CMR is a powerful tool to aid in the diagnosis of cardiomyopathy in athletes. It may also have a future role in assessing fibrosis related to long-term participation in sport.

摘要

综述目的

心血管磁共振成像(CMR)常用于对疑似患有心脏病的运动员进行检查。在本综述中,我们讨论CMR如何用于疑似心肌病的运动员,尤其涉及容积分析和组织特征描述。我们还讨论了在运动员中发现的非缺血性纤维化,描述其患病率、分布及临床重要性。

最新发现

CMR的优势包括高空间分辨率、不受限制的成像平面以及无电离辐射。经常进行体育锻炼会导致心脏重塑,在某些情况下,临床上很难将其与各种心肌病区分开来。CMR进行全面的形态学评估是确保准确诊断的基础。通过延迟钆增强和T1映射进行组织特征描述的进展,有可能成为应对这一具有挑战性临床情况的有力辅助工具。使用延迟钆增强,还可以在没有明显心肌病的运动员中检测到非缺血性纤维化。这种纤维化的机制尚不清楚;然而,它在临床上似乎很重要。我们还回顾了关于运动员中非缺血性纤维化患病率的数据。CMR是辅助诊断运动员心肌病的有力工具。它在评估与长期参与运动相关的纤维化方面可能也有未来的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e1/6132733/142bc1419fe1/11936_2018_679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e1/6132733/142bc1419fe1/11936_2018_679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e1/6132733/142bc1419fe1/11936_2018_679_Fig1_HTML.jpg

相似文献

1
The Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future Perspectives.心血管磁共振成像在运动心脏病学中的作用:当前应用与未来展望
Curr Treat Options Cardiovasc Med. 2018 Aug 31;20(10):86. doi: 10.1007/s11936-018-0679-y.
2
Cardiac magnetic resonance assessment of athletic myocardial fibrosis; Benign bystander or malignant marker?运动性心肌纤维化的心脏磁共振评估:良性旁观者还是恶性标志物?
Int J Cardiol. 2024 Jan 1;394:131382. doi: 10.1016/j.ijcard.2023.131382. Epub 2023 Sep 22.
3
Imaging focal and interstitial fibrosis with cardiovascular magnetic resonance in athletes with left ventricular hypertrophy: implications for sporting participation.应用心血管磁共振成像评估运动员左心室肥厚的局灶性和间质纤维化:对运动参与的影响。
Br J Sports Med. 2012 Nov;46 Suppl 1:i69-77. doi: 10.1136/bjsports-2012-091482.
4
Certainties and Uncertainties of Cardiac Magnetic Resonance Imaging in Athletes.运动员心脏磁共振成像的确定性与不确定性
J Cardiovasc Dev Dis. 2022 Oct 20;9(10):361. doi: 10.3390/jcdd9100361.
5
Assessment of myocardial changes in athletes with native T1 mapping and cardiac functional evaluation using 3 T MRI.使用3T磁共振成像通过天然T1映射评估运动员的心肌变化及心脏功能评估
Int J Cardiovasc Imaging. 2016 Jun;32(6):975-81. doi: 10.1007/s10554-016-0866-4. Epub 2016 Feb 27.
6
High spatial resolution free-breathing 3D late gadolinium enhancement cardiac magnetic resonance imaging in ischaemic and non-ischaemic cardiomyopathy: quantitative assessment of scar mass and image quality.高空间分辨率自由呼吸 3D 晚期钆增强心脏磁共振成像在缺血性和非缺血性心肌病中的应用:瘢痕质量和图像质量的定量评估。
Eur Radiol. 2018 Sep;28(9):4027-4035. doi: 10.1007/s00330-018-5361-y. Epub 2018 Apr 6.
7
The usefulness of cardiovascular magnetic resonance imaging in children with myocardial diseases.心血管磁共振成像在患有心肌疾病儿童中的应用价值。
Kardiol Pol. 2015;73(6):419-28. doi: 10.5603/KP.a2014.0239. Epub 2015 Jan 7.
8
Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.通过离体钆增强磁共振成像及组织病理学相关性对年龄相关大鼠模型中心肌纤维化进行定量评估。
Comput Biol Med. 2015 Oct 1;65:103-13. doi: 10.1016/j.compbiomed.2015.07.027. Epub 2015 Aug 8.
9
Clinical implications of cardiac magnetic resonance imaging fibrosis.心脏磁共振成像纤维化的临床意义。
Eur Heart J Suppl. 2022 Nov 12;24(Suppl I):I123-I126. doi: 10.1093/eurheartjsupp/suac085. eCollection 2022 Nov.
10
Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.肥厚型心肌病的心血管磁共振成像:当前技术水平
Cardiol J. 2016;23(3):250-63. doi: 10.5603/CJ.a2016.0019. Epub 2016 Apr 11.

引用本文的文献

1
Left Ventricular Hypertrabeculation (LVHT) in Athletes: A Negligible Finding?运动员左心室小梁增多(LVHT):一个可忽略的发现?
Medicina (Kaunas). 2024 Dec 28;61(1):32. doi: 10.3390/medicina61010032.
2
Non-specific myocardial fibrosis in young competitive athletes: clinical significance and risk prediction by a powerful machine learning-based model.年轻竞技运动员的非特异性心肌纤维化:基于强大机器学习模型的临床意义及风险预测
Clin Res Cardiol. 2024 Oct 14. doi: 10.1007/s00392-024-02550-y.
3
The Role of Cardiovascular Imaging in the Diagnosis of Athlete's Heart: Navigating the Shades of Grey.

本文引用的文献

1
Exercise cardiac magnetic resonance to differentiate athlete's heart from structural heart disease.运用心脏磁共振来区分运动员心脏与结构性心脏病。
Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1062-1070. doi: 10.1093/ehjci/jey050.
2
Global and regional cardiac function in lifelong endurance athletes with and without myocardial fibrosis.有和没有心肌纤维化的终身耐力运动员的整体和局部心脏功能
Eur J Sport Sci. 2017 Nov;17(10):1297-1303. doi: 10.1080/17461391.2017.1373864. Epub 2017 Sep 14.
3
Cardiac damage in athlete's heart: When the "supernormal" heart fails!
心血管成像在运动员心脏诊断中的作用:把握灰色地带
J Imaging. 2024 Sep 14;10(9):230. doi: 10.3390/jimaging10090230.
4
Myocardial Fibrosis in Young and Veteran Athletes: Evidence from a Systematic Review of the Current Literature.年轻和资深运动员的心肌纤维化:来自当前文献系统综述的证据
J Clin Med. 2024 Aug 2;13(15):4536. doi: 10.3390/jcm13154536.
5
No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes.男性耐力运动员的运动暴露与弥漫性心肌纤维化之间无不良关联。
Sci Rep. 2024 Mar 19;14(1):6581. doi: 10.1038/s41598-024-57233-5.
6
Role of cardiac magnetic resonance imaging in troponinemia syndromes.心脏磁共振成像在肌钙蛋白血症综合征中的作用。
World J Cardiol. 2022 Apr 26;14(4):190-205. doi: 10.4330/wjc.v14.i4.190.
7
The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Myocardial Fibrosis in Young and Veteran Athletes: Insights From a Meta-Analysis.心血管磁共振成像在评估年轻和资深运动员心肌纤维化中的作用:一项荟萃分析的见解
Front Cardiovasc Med. 2021 Dec 21;8:784474. doi: 10.3389/fcvm.2021.784474. eCollection 2021.
8
Preparticipation medical evaluation for elite athletes: EFSMA recommendations on standardised preparticipation evaluation form in European countries.精英运动员参赛前医学评估:欧洲运动医学联合会关于欧洲国家标准化参赛前评估表的建议
BMJ Open Sport Exerc Med. 2021 Oct 19;7(4):e001178. doi: 10.1136/bmjsem-2021-001178. eCollection 2021.
9
Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation.2019年冠状病毒病:心脏并发症及恢复运动参与的考量
Eur Cardiol. 2021 Mar 2;16:e03. doi: 10.15420/ecr.2020.36. eCollection 2021 Feb.
10
Myocardial fibrosis in athletes-Current perspective.运动员心肌纤维化——当前的观点。
Clin Cardiol. 2020 Aug;43(8):882-888. doi: 10.1002/clc.23360. Epub 2020 Mar 19.
运动员心脏的心脏损伤:当“超常”心脏衰竭时!
World J Cardiol. 2017 Jun 26;9(6):470-480. doi: 10.4330/wjc.v9.i6.470.
4
Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile.低动脉粥样硬化风险特征的耐力项目大师运动员的亚临床冠状动脉疾病的流行率。
Circulation. 2017 Jul 11;136(2):126-137. doi: 10.1161/CIRCULATIONAHA.116.026964. Epub 2017 May 2.
5
International Recommendations for Electrocardiographic Interpretation in Athletes.国际运动员心电图解读建议。
J Am Coll Cardiol. 2017 Feb 28;69(8):1057-1075. doi: 10.1016/j.jacc.2017.01.015.
6
Myocardial Fibrosis in Athletes.运动员心肌纤维化。
Mayo Clin Proc. 2016 Nov;91(11):1617-1631. doi: 10.1016/j.mayocp.2016.07.012. Epub 2016 Oct 6.
7
Prominent left ventricular trabeculations in competitive athletes: A proposal for risk stratification and management.竞技运动员左心室粗大肌小梁:风险分层与管理建议
Int J Cardiol. 2016 Nov 15;223:590-595. doi: 10.1016/j.ijcard.2016.08.272. Epub 2016 Aug 17.
8
No evidence of adverse cardiac remodeling in former elite endurance athletes.前精英耐力运动员未出现心脏不良重塑的证据。
Int J Cardiol. 2016 Nov 1;222:171-177. doi: 10.1016/j.ijcard.2016.07.197. Epub 2016 Jul 30.
9
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.LGE-CMR 在 HCM 中的预后价值:一项荟萃分析。
JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402. doi: 10.1016/j.jcmg.2016.02.031. Epub 2016 Jul 20.
10
Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes.非缺血性左心室瘢痕作为竞技运动员危及生命的室性心律失常和心源性猝死的基质。
Circ Arrhythm Electrophysiol. 2016 Jul;9(7):e004229. doi: 10.1161/CIRCEP.116.004229.